(Reuters) - St. Jude Medical Inc said the U.S. Food and Drug Administration notified the company that issues regarding its Sylmar, California-based manufacturing plant have been resolved. The FDA last year had warned St. Jude of serious violations at the plant where the Durata and Riata leads for implantable defibrillators are made. Violations included a failure to validate testing methods. [ID:nL2N0D40KS] Implantable heart defibrillators are small devices that are placed in the chest to correct irregular heart beat. Durata and Riata leads are wires that connect this device to the heart. St. ...
via Health News Headlines - Yahoo News http://ift.tt/1xgJAD5
via Health News Headlines - Yahoo News http://ift.tt/1xgJAD5
No comments:
Post a Comment